AGX vs PFE · P/E 31, rev $674.9M vs P/E 20, rev $15.03B
Argan Inc (AGX) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Argan Inc (AGX) is a engineering & construction company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported AGX revenue for 2026-07-31 was $674.9M. Net income was $99.4M. AGX currently screens at market cap $3.00B and trailing P/E 30.7.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
AGX currently screens at market cap $3.00B and trailing P/E 30.7. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the AGX and PFE stock pages for the full models.
Not investment advice.